+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Soliton Inc (SOLY) - Product Pipeline Analysis, 2021 Update

  • PDF Icon

    Company Profile

  • 30 Pages
  • December 2021
  • GlobalData
  • ID: 5519803
Soliton Inc (Soliton) is a medical device company. It is engaged in developing and commercializing aesthetic devices. The company is developing Rapid Acoustic Pulse (RAP) device which is used for removal of tattoos. It develops technology in partnership with GE and Sanmina. The company is developing acoustic devices for the treatment of cellulite and other indications. The company's products technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment. Soliton is headquartered in Houston, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Soliton Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:


  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Soliton Inc Company Overview
  • Soliton Inc Company Snapshot
  • Soliton Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Soliton Inc - Pipeline Analysis Overview
  • Soliton Inc - Key Facts
  • Soliton Inc - Major Products and Services
  • Soliton Inc Pipeline Products by Development Stage
  • Soliton Inc Ongoing Clinical Trials by Trial Status
  • Soliton Inc Pipeline Products Overview
  • RESONIC Device - Fibrotic Scars
  • RESONIC Device - Fibrotic Scars Product Overview
  • RESONIC Device - Fibrotic Scars Clinical Trial
  • RESONIC Device - Generation 2
  • RESONIC Device - Generation 2 Product Overview
  • RESONIC Device - Generation 3
  • RESONIC Device - Generation 3 Product Overview
  • RESONIC Device - Liver Fibrosis
  • RESONIC Device - Liver Fibrosis Product Overview
  • RESONIC Device - Skin Laxity
  • RESONIC Device - Skin Laxity Product Overview
  • RESONIC Device - Subcutaneous Fat Reduction
  • RESONIC Device - Subcutaneous Fat Reduction Product Overview
  • Soliton Inc - Key Competitors
  • Soliton Inc - Key Employees
  • Soliton Inc - Locations And Subsidiaries
  • Head Office
Recent Developments
  • Soliton Inc, Recent Developments
Mar 09, 2021: Soliton announces initiation of second animal study for potential RAP treatment of liver fibrosis
Aug 20, 2020: Soliton announces presentations at Masters in Aesthetics Symposium
Mar 11, 2020: Soliton receives FDA clearance of Special 510(k)
Mar 09, 2020: Soliton signs agreement with global manufacturer Sanmina
Mar 03, 2020: Soliton to present pivotal cellulite clinical trial results at AAD on March 21, 2020
Jan 27, 2020: Soliton announces positive data from extended keloid and hypertrophic scar trials
Jan 13, 2020: Soliton to announce keloid and hypertrophic scar clinical 12-week trial data at Maui Derm meeting
Dec 03, 2019: Soliton initiates significant step towards commercialization
Nov 12, 2019: Soliton announces first follow-up visit conducted in the pivotal Cellulite clinical trial
Nov 05, 2019: Soliton completes treatment of all patients in pivotal cellulite trial
Appendix
  • Methodology
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Soliton Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Soliton Inc Pipeline Products by Equipment Type
  • Soliton Inc Pipeline Products by Indication
  • Soliton Inc Ongoing Clinical Trials by Trial Status
  • Soliton Inc, Key Facts
  • Soliton Inc, Major Products and Services
  • Soliton Inc Number of Pipeline Products by Development Stage
  • Soliton Inc Pipeline Products Summary by Development Stage
  • Soliton Inc Ongoing Clinical Trials by Trial Status
  • Soliton Inc Ongoing Clinical Trials Summary
  • RESONIC Device - Fibrotic Scars - Product Status
  • RESONIC Device - Fibrotic Scars - Product Description
  • RESONIC Device - Fibrotic Scars - Soliton's Rapid Acoustic Pulse (RAP) Device for the Treatment of Fibrotic Scars: Multi-treatment Proof-of-concept Study
  • RESONIC Device - Generation 2 - Product Status
  • RESONIC Device - Generation 2 - Product Description
  • RESONIC Device - Generation 3 - Product Status
  • RESONIC Device - Generation 3 - Product Description
  • RESONIC Device - Liver Fibrosis - Product Status
  • RESONIC Device - Liver Fibrosis - Product Description
  • RESONIC Device - Skin Laxity - Product Status
  • RESONIC Device - Skin Laxity - Product Description
  • RESONIC Device - Subcutaneous Fat Reduction - Product Status
  • RESONIC Device - Subcutaneous Fat Reduction - Product Description
  • Soliton Inc, Key Employees
  • Glossary

List of Figures
  • Soliton Inc Pipeline Products by Equipment Type
  • Soliton Inc Pipeline Products by Development Stage
  • Soliton Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Venus Concept Inc
  • Merz North America Inc
  • Cypris Medical, Inc.